Timely and accurate RB1 genetic testing guides familial risk stratification in heritable retinoblastoma.

Abstract excerpt

With the availability of high-sensitivity molecular genetic testing, prenatal diagnosis by amniocentesis, early-term delivery of at-risk neonates, and hand-held optical coherence tomography for detection of subclinical tumors, there is an opportunity to optimize eye and vision salvage and minimize the burden of invasive treatments in hereditary retinoblastoma. Providing this standard of care requires consistent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Infant